3 ms·
How many other small bets did NewLink place on promising technologies coming out of academic labs, and how many of them panned out? Put another way, was 200k a
by chockablock 11y ago
How many other small bets did NewLink place on promising technologies coming out of academic labs, and how many of them panned out? Put another way, was 200k a fair market rate for the license at the time they paid it, or do you have reason to suspect corruption or malfeasance?
- tw04 11y agoHow could you not assume corruption? This is Ebola we're talking about. It wasn't "if" it was "when".
- chockablock 11y ago>This is Ebola we're talking about. It wasn't "if" it was "when" Before 2014, there had been no outbreaks that had infected more than a few hundred people. ( www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html ) > How could you not assume corruption? Even after the large 2014 outbreak, Merck claims that they do not view the development of the vaccine as "a commercial opportunity", but rather as being good for PR and for employee retention. ( http://www.cnbc.com/2015/07/31/will-merck-ebola-vaccine-make-money.html http://www.cnbc.com/2015/07/31/will-merck-ebola-vaccine-make... ) Is the only evidence of corruption the small initial licensing fee? If so, note that the terms of the license to NewLink also include royalties due to the Canadian government in the case of successful commercialization ( http://www.sec.gov/Archives/edgar/data/1126234/000104746911009169/a2206169zex-10_67.htm http://www.sec.gov/Archives/edgar/data/1126234/0001047469110... ).